Objectives: Our group is involved in the following tasks:
Next generation sequencing (NGS) to identify novel genes for cardiomyopathies
Functional characterization of cardiomyopathies using patient specific induced pluripotent stem cells (hiPSCs)
An in vivo large- scale small molecules screening using Drosophila model
Humanized transgenic mouse model of cardiomyopathy
Role of RAF1 in cancer and cardiomyopathy